Dr. Marissa Salazar Cantu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-2078 Fax: 210-358-1972 |
Dr. Yan Meng, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 |
James Travis Jenkins, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-3000 |
Dr. Deanna Dance-kwan, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 7700 Floyd Curl, San Antonio, TX 78229 Phone: 210-871-4409 Fax: 210-524-9599 |
Theodore Arevalo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 |
Dr. Joshua David Hernandez, DO Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 3333 Research Plz, San Antonio, TX 78235 Phone: 210-297-3000 |
Uzair Mushtaq, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 |
Dr. Ashley Varnon Aleman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1434 E Sonterra Blvd, San Antonio, TX 78258 Phone: 210-402-3456 Fax: 210-402-3233 |
Dr. Lashandra L. Royster-adams, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4330 Medical Dr, Ste 500, San Antonio, TX 78229 Phone: 210-576-5306 Fax: 210-694-0645 |
Danielle Ramirez, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 5430 Fredericksburg Rd, San Antonio, TX 78229 Phone: 210-541-8281 |
Anum Jalil, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 |
News Archive
Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease.
Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.
Four unhealthy behaviors—smoking, lack of physical activity, poor diet and alcohol consumption—appear to be associated with a substantially increased risk of death when combined, according to a report in the April 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
With just two days to negotiate an agreement with Republican lawmakers before a potential government shutdown, Gov. Mark Dayton and Republican leaders are trying to find additional cuts in health and human services spending, the fastest-growing part of state government.
› Verified 7 days ago